Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival.
about
Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?Current prognostic and predictive factors in follicular lymphoma.B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.Minimally invasive in tumor multidrug comparative analysis with contrast-enhanced MRI in mice.Evaluation of tenascin-C by tenatumomab in T-cell non-Hodgkin lymphomas identifies a new target for radioimmunotherapy.
P2860
Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Rate of primary refractory dis ...... ation with long-term survival.
@ast
Rate of primary refractory dis ...... ation with long-term survival.
@en
Rate of primary refractory dis ...... ation with long-term survival.
@nl
type
label
Rate of primary refractory dis ...... ation with long-term survival.
@ast
Rate of primary refractory dis ...... ation with long-term survival.
@en
Rate of primary refractory dis ...... ation with long-term survival.
@nl
prefLabel
Rate of primary refractory dis ...... ation with long-term survival.
@ast
Rate of primary refractory dis ...... ation with long-term survival.
@en
Rate of primary refractory dis ...... ation with long-term survival.
@nl
P2093
P2860
P50
P1433
P1476
Rate of primary refractory dis ...... ation with long-term survival.
@en
P2093
Alessandro Rambaldi
Andrea Rossi
Anna Maria Barbui
Corrado Tarella
Daniela Gottardi
Daniele Caracciolo
Federica Delaini
Riccardo Bruna
Roberto Passera
P2860
P304
P356
10.1371/JOURNAL.PONE.0106745
P407
P577
2014-09-25T00:00:00Z